Drawing for FLAMEL TECHNOLOGIES

USPTO serial 77224518

FLAMEL TECHNOLOGIES

Reviewed by CopyMark Law Group

Reg. 3574585Status 710
Filing date
Status date
Registration date
Feb 17, 2009
Examiner
SNAPP, TINA LOUISE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with FLAMEL TECHNOLOGIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa A. Dunner

Lisa A. Dunner Dunner Law PLLC3243 P Street, NWWashington, DC 20007UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in the manufacture of drugs; fertilizers for domestic and agricultural use; ceramic matrix composite materials (CMC) for manufacturing use in the aeronautics industry; photographic chemicals; unprocessed artificial resins; descaling agents, namely, detergents in the industrial and consumer cleaning products industry; biopolymers, proteins, glycoproteins, polyaminoacids, collagens, co-polymers from lactic/glycolic carboylic acids for use in the manufacture of drugs and biological materials; chemicals, namely, polymers, plastic polymers, spiropyrans, naphthopyrans, and chromens for use in the manufacture of optical devices and non-linear optical devicesSECTION 8 - CANCELLED—
002Colorants for use in the manufacture of paint, pigments, dyes for use in the manufacture of optical glasses and lenses; colorants, namely, photochromic compounds for use in the manufacture of paint, pigments, dyes for use in the manufacture of optical glasses and lenses; colorants for use in the manufacture of washing and cosmetic productsSECTION 8 - CANCELLED—
003Cosmetics, dishwashing detergents, personal deodorants, stain removers, washing products, namely, windshield washing fluid; soaps, namely, deodorant soap, essential oils for personal use, essential oils for personal use and perfumesSECTION 8 - CANCELLED—
005All purpose disinfectants; pharmaceutical preparations for the treatment of heart diseases, pain, diabetes, and cardiovascular diseases; vaccines; veterinary vaccines for bovines, sheep, and horses; sanitary napkins; dietary supplements; dressing for wounds, burns, and surgical purposes; fungicides for agricultural use and domestic use; herbicides for agricultural use and domestic use; weed killers for agricultural use and domestic use; insecticides for agricultural use and domestic use; medicines for the treatment of heart diseases, pain, diabetes, and cardiovascular diseases; medicines with delayed release of the active principles for the treatment of heart diseases, pain, diabetes, and cardiovascular diseases; medicines with encapsulated active principle biocides for the treatment of heart diseases, pain, diabetes, and cardiovascular diseases; medicines based on aspirin, insulin, metformine, aciclovir, glibenclamide for the treatment of heart diseases, pain, diabetes, and cardiovascular diseases; medicines based on encapsulated aspirin, insulin, metformine, aciclovir, glibenclamide for the delayed release of the active principle for the treatment of heart disease, pain, diabetes, and cardiovascular diseases; liquid pharmaceutical preparations for oral administration and injection and allowing for the delayed release of the pharmaceutical active principles for the treatment of heart diseases, pain, diabetes, and cardiovascular diseasesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 18, 2015C8..CANCELLED SEC. 8 (6-YR)—
Nov 18, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 17, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 2, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 12, 2008NPUBNOTICE OF PUBLICATION—
Oct 29, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 28, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 3, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 3, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2008ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 11, 2008GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 11, 2008GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 11, 2008CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 19, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 19, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 19, 2008ALIEASSIGNED TO LIE—
Feb 29, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 29, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 4, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 4, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 4, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 1, 2007DOCKASSIGNED TO EXAMINER—
Jul 12, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance